| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/19/2013 | US8377951 Transdermal administration of phycotoxins |
| 02/19/2013 | US8377917 Polymeric prodrug with a self-immolative linker |
| 02/19/2013 | US8377916 Steroids as agonists for FXR |
| 02/19/2013 | US8377897 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 02/19/2013 | US8377868 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 02/19/2013 | US8377863 Peptide pharmaceutical for oral delivery |
| 02/19/2013 | US8377679 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 02/19/2013 | US8377654 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
| 02/19/2013 | US8377483 Bioactivation of iron salt, especially an ferric ferrous salt, by adding a magnesium salt (MgCl2); useful as a medicine to treat diseases such as diabetes, freshness preservative agent, and animal and plant growth promoter |
| 02/19/2013 | US8377481 Apparatus and method to generate a mixture of hydrogen peroxide gas and a carrier gas |
| 02/19/2013 | US8377480 Granular sustained release preparation and production thereof |
| 02/19/2013 | US8377477 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof |
| 02/19/2013 | US8377472 Orally dispersible tablet with low friability and method for preparing same |
| 02/19/2013 | US8377456 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives |
| 02/19/2013 | US8377451 Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| 02/19/2013 | US8377445 Compositions of human lipids and methods of making and using same |
| 02/19/2013 | CA2581493C Taste-masking pharmaceutical compositions |
| 02/19/2013 | CA2577345C Jelly composition |
| 02/19/2013 | CA2570450C Pharmaceutically elegant, topical anhydrous aerosol foam |
| 02/19/2013 | CA2566433C Therapeutic agent for bh4-responsive hyperphenylalaninemia |
| 02/19/2013 | CA2563870C Pharmaceutical compositions comprising old man's beard (usnea barbata) and st.john's wort (hypericum perforatum) and their use |
| 02/19/2013 | CA2560981C Polymer-based sustained release device |
| 02/19/2013 | CA2560874C Poly (lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar |
| 02/19/2013 | CA2559607C Immune response modifier formulations and methods |
| 02/19/2013 | CA2551525C Pharmaceutical composition for thrombin peptide derivatives |
| 02/19/2013 | CA2528313C Nail restructuring compositions for topical application |
| 02/19/2013 | CA2512780C Multivalent constructs that bind the vegf receptor-2 kdr for therapeutic and diagnostic applications |
| 02/19/2013 | CA2372947C Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue |
| 02/14/2013 | WO2013023064A2 Composite matrix for bone repair applications |
| 02/14/2013 | WO2013022949A1 Encapsulates |
| 02/14/2013 | WO2013022783A2 Progesterone containing oral dosage forms and related methods |
| 02/14/2013 | WO2013022354A1 Methods and compositions for improving sperm functionality |
| 02/14/2013 | WO2013022201A1 Process of preparing a stabilized and solubilized formulation of sirolimus derivatives |
| 02/14/2013 | WO2013022090A1 Highly functional cellulose composite |
| 02/14/2013 | WO2013022059A1 Pharmaceutical composition containing diamine derivative |
| 02/14/2013 | WO2013022052A1 Medicinal agent for medical applications, and method for searching for novel medicinal agent |
| 02/14/2013 | WO2013021935A1 Compound for treating cartilage disorders |
| 02/14/2013 | WO2013021836A1 Functional hydrogel |
| 02/14/2013 | WO2013021660A1 Coated preparation containing azosemide as active ingredient |
| 02/14/2013 | WO2013021353A1 Surface modified proteinaceous spherical particles and uses thereof |
| 02/14/2013 | WO2013021249A1 Degradation-resistant cross-linked, low-molecular-weight hyaluronate |
| 02/14/2013 | WO2013021143A1 Injectable solution of at least one type of basal insulin |
| 02/14/2013 | WO2013021126A1 Packaged dianhydrohexitols having high chemical stability |
| 02/14/2013 | WO2013021056A1 Method for the controlled intracellular delivery of nucleic acids |
| 02/14/2013 | WO2013020986A1 Polyanion nanocomplexes for therapeutic applications |
| 02/14/2013 | WO2013020917A1 Ophthalmologic composition comprising an aqueous solution of at least one viscoelastic polysaccharide |
| 02/14/2013 | WO2013020914A1 Peg-conjugated peptides |
| 02/14/2013 | WO2013020899A1 Multiple emulsion |
| 02/14/2013 | WO2013020527A1 Utilization of alaptide as transdermal penetration modifier in pharmaceutical compositions for human and veterinary applications containing anti-inflammatory drugs and/or antimicrobial chemotherapeutics |
| 02/14/2013 | WO2013020302A1 Diclofenac sodium sustained release tablet and preparation process therefor |
| 02/14/2013 | WO2013020204A1 Polymeric nanoparticles for photosensitizers |
| 02/14/2013 | WO2012173003A3 Medical tissue-marker and manufacturing method for same |
| 02/14/2013 | WO2012140433A4 System for purifying, producing and storing biomelecules |
| 02/14/2013 | WO2004112836A8 Ophthalmic compositions containing a synergistic combination of two polymers |
| 02/14/2013 | US20130041046 Sweet flavor modifier |
| 02/14/2013 | US20130041045 Functionalized diphenolics and absorbable polymers therefrom |
| 02/14/2013 | US20130041044 Phase separated composite |
| 02/14/2013 | US20130041043 Excipient from trigonella foenum-graceum seeds and process for preparation thereof |
| 02/14/2013 | US20130041042 Polymeric compositions and articles of manufacture for wound and burn treatment and other uses |
| 02/14/2013 | US20130041006 Pharmaceutical composition for intracellar acidification with cis-urocanic acid |
| 02/14/2013 | US20130040980 Cci-779 concentrate formulations |
| 02/14/2013 | US20130040891 Chemically modified water-soluble elastin, mixed gel of chemically modified water-soluble elastin and collagen, and process for producing same |
| 02/14/2013 | US20130040884 Albumin-binding conjugates comprising fatty-acid and peg |
| 02/14/2013 | US20130039990 Injectable, load-bearing cell/microbead/calcium phosphate bone paste for bone tissue engineering |
| 02/14/2013 | US20130039986 Silk-Based Ionomeric Compositions |
| 02/14/2013 | US20130039932 Quickly soluble oral film dosage containing steviosides as a unpleasant taste masking agent |
| 02/14/2013 | US20130039901 Treatment of Pompe's Disease |
| 02/14/2013 | US20130039880 Cyclodextrin-based polymers for therapeutics delivery |
| 02/14/2013 | US20130039879 Ophthalmic Compositions Containing A Synergistic Combination Of Two Polymers |
| 02/14/2013 | US20130039864 Non-Intravenous Dosage Form Comprising Solid Formulation of Liquid Biologically Active Agent and Uses Thereof |
| 02/14/2013 | US20130039862 Compounds of dibenzylidene sorbitol ester type, process of preparation, use, compositions comprising them and cosmetic treatment method |
| 02/14/2013 | CA2847298A1 Multiple emulsion |
| 02/14/2013 | CA2844668A1 Methods and compositions for the treatment of autoimmune and inflammatory diseases |
| 02/14/2013 | CA2844604A1 Pharmaceutical composition containing diamine derivative |
| 02/14/2013 | CA2844553A1 Cabazitaxel formulations and methods of preparing thereof |
| 02/14/2013 | CA2843837A1 Methods and compositions for improving sperm functionality |
| 02/14/2013 | CA2843687A1 Packaged dianhydrohexitols having high chemical stability |
| 02/14/2013 | CA2843640A1 N-glycosylated insulin analogues |
| 02/14/2013 | CA2843586A1 Injectable solution of at least one type of basal insulin |
| 02/14/2013 | CA2842348A1 Encapsulates |
| 02/13/2013 | EP2557155A1 Metal salen complex derivative and process for production thereof |
| 02/13/2013 | EP2556825A1 Multicomponent pharmaceutical dosage form |
| 02/13/2013 | EP2556149A1 Cell poration |
| 02/13/2013 | EP2556085A2 Protease-activatable pore-forming polypeptides |
| 02/13/2013 | EP2555802A1 Methods and compositions for enhanced delivery of compounds |
| 02/13/2013 | EP2555800A1 Enhancement of radiation therapy by targeted high-z nanoparticles |
| 02/13/2013 | EP2555797A1 Tnf- binding proteins |
| 02/13/2013 | EP2555779A1 Glycomimetic compounds and methods to inhibit infection by hiv |
| 02/13/2013 | EP2555760A1 Methods and compositions for treating wounds utilizing chitosan compounds |
| 02/13/2013 | EP2555737A2 Miniature ingestible device |
| 02/13/2013 | CN1893982B Menthol-containing preparation |
| 02/13/2013 | CN102933705A Decellularized adipose tissue |
| 02/13/2013 | CN102933658A Local delivery of drugs from self assembled coatings |
| 02/13/2013 | CN102933237A Conjugates for the prevention or treatment of nicotine addiction |
| 02/13/2013 | CN102933236A Pyrrolobenzodiazepines and conjugates thereof |
| 02/13/2013 | CN102933235A Halogenated ether complex |
| 02/13/2013 | CN102933234A Methods for the preparation of injectable depot compositions |
| 02/13/2013 | CN102933233A Agent for treating renal fibrosis |
| 02/13/2013 | CN102933230A Methods and compositions for intranasal delivery |
| 02/13/2013 | CN102933209A Adhesive composition for medical use, adhesive patch for medical use, and method for producing the composition |